UK markets open in 1 hour 54 minutes

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
146.95-0.42 (-0.28%)
At close: 06:14PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3N/A
S&P500 52-week change 3-9.08%
52-week high 3147.40
52-week low 3146.93
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.5B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.90%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 35.64
Trailing annual dividend yield 33.83%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 23.19%
Operating margin (ttm)37.21%

Management effectiveness

Return on assets (ttm)9.27%
Return on equity (ttm)90.65%

Income statement

Revenue (ttm)57.82B
Revenue per share (ttm)32.64
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)38.88B
EBITDA 29.8B
Net income avi to common (ttm)13.34B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)24.20%

Balance sheet

Total cash (mrq)11.88B
Total cash per share (mrq)6.72
Total debt (mrq)70B
Total debt/equity (mrq)436.76
Current ratio (mrq)0.93
Book value per share (mrq)9.04

Cash flow statement

Operating cash flow (ttm)22.59B
Levered free cash flow (ttm)20.2B